• Skip to main content
  • Skip to footer
  • Home
  • About
    • MyPE Copyright Terms
    • Authors
    • Deals
  • Info
    • Accommodation
    • Classified Adverts
    • Directory
    • Essential PE Numbers
    • Flight Schedules
    • Forex Converter
    • PE’s Online Radio Stations
      • Algoa FM
      • Bay FM
      • iFM
      • Kingfisher FM
      • MannMade Radio
      • Madibaz Radio
      • Umhlobo Wenene
    • Podcasts
    • Shipping
    • Street Map
    • Tides
    • Ward Details
    • Ward News
    • Weather
  • Contact
    • Advertising on MyPE
  • Submit
    • Blogger
    • 5 Quick PE Questions
    • Entertainment
    • Events
      • Add your Port Elizabeth event
    • Letter to the Editor
    • Lost and Found
    • Movers and Shakers
    • News Article
    • PE Videos
    • Photographs
    • Recipes
    • Traffic Hooligan
    • Say NO
  • Dam Levels
  • Advertorial
  • Business
  • NMBRA
  • NMB Rates
MyPE

MyPE

Community Business Directory, Event Listings, News and Views from Gqeberha, Nelson Mandela Bay

SA scientists have ability to produce vaccines

18 January 2021 By Alan Straton

South Africa has technical capabilities to produce vaccines as the country battles with the COVID-19 resurgence.

According to the Higher Education and Training Minister, Dr Blade Nzimande, the threat of future pandemics, has propelled the country’s ability to develop and manufacture vaccines locally into the spotlight.

“Why can’t we produce in South Africa because we’ve produced other vaccines, with the scientist capacity that we have and infrastructure,” Nzimande asked.

Nzimande told the media on Monday that government, through the Department of Science and Innovation (DSI), owns a 47.5% stake in Biovac, a biopharmaceutical company.

“The company has over the years developed the capability to manufacture vaccines,” he said.

Last year, the Minister launched an initiative, which sees Biovac manufacturing Hexaxim in partnership with Sanofi.

Hexaxim is the world’s first liquid hexavalent vaccine that protects against diphtheria, tetanus, whooping cough, hepatitis B, Haemophilus influenza type B, and poliomyelitis.

“So, we do have a foundation that we need to build on,” he stressed.

It is also the first World Health Organisation Expanded Programme on Immunisation vaccine to be manufactured in South Africa, which he believes is a strong indication of the technical abilities of South African scientists.

Also, two studies are currently being supported in the area of immunisations.

“The first is a study on plant-based manufacturing of antibodies for COVID-19, which aims to facilitate the rapid development of SARS-CoV-2 vaccines, therapeutic antibodies and diagnostic reagents utilising various expression platforms for advancing the production of SARS-CoV-2 vaccine candidates and reagents,” he explained.

Meanwhile, the Council for Scientific and Industrial Research (CSIR) has entered into an agreement with Kentucky Biological Products (KBP) for the potential manufacturing of the antigen of their vaccine and expressed interest in testing their vaccine in South Africa.

The second is a ChAdOx1-nCOV-19 vaccine trial, in partnership with the department, South African Medical Research Council and the University of the Witwatersrand.

The study is aimed at assessing the safety, immunogenicity and efficacy of a COVID-19 vaccine candidate (ChAdOx1 SARS-CoV-2) in South African adults living without HIV.

“This is part of an international study aimed at finding a vaccine that will prevent infection by the virus that causes COVID-19, but also assessing whether the vaccines will be effective in local settings.”

In addition, the vaccine developed at the Oxford University Jenner Institute, in collaboration with AstraZeneca is currently being trialled in a number of countries, including South Africa.

“Preliminary results indicate that this vaccine could reduce virus transmission based on an observed reduction in asymptomatic infections.”

The vaccine is at least 62% effective when given in two full-strength doses, compared to the 94% efficacy achieved by Pfizer and Moderna candidate vaccines, he said.

“Of the few vaccines approved globally, the Oxford vaccine, while not as effective as the Pfizer and Moderna vaccines have been touted as the most suitable for developing countries due to its cost, and because it is comparatively easy to transport, store and distribute.”

5G and other COVID-19 myths

The Minister has also rubbished false stories that are spread about vaccines.

“This thing about people questioning vaccines now has a danger of misleading people,” he stressed.

“All of us when we are born we’re vaccinated, even children who are born now as we’re speaking they’re being vaccinated against polio and all these other diseases.”

He said vaccines are not new and go through vigorous scientist testing.

“This thing that the 5G is bringing COVID-19 is not true and many other stories being told about COVID-19 that are not there.”

The department will also convene a panel of scientists to provide a platform to share with society on what science is saying about the role of vaccination in the fight against COVID-19 and bust the myths about vaccination.

He will also be organising an imbizo to analyse and come up with concrete suggestions to government and society as a whole on how to deal with the psychosocial impact of Coronavirus on families, communities and society as a whole. – SAnews.gov.za

The following two tabs change content below.
  • Bio
  • Latest Posts
My Twitter profileMy Facebook profileMy Google+ profileMy LinkedIn profileMy Flickr profileMy Pinterest profile

Alan Straton

Chief Cook, Bottle Washer and Broom Mechanic at MyPE
Passionate about Port Elizabeth and definitely NOT packing for Perth. Alan's ethos is epitomised in the words of Nelson Mandela; "I have fought against white domination and I have fought against black domination. I have cherished the idea of a democratic and free society. If need be, it is an ideal for which I am prepared to die." See more articles by Alan.
My Twitter profileMy Facebook profileMy Google+ profileMy LinkedIn profileMy Flickr profileMy Pinterest profile

Latest posts by Alan Straton (see all)

  • Mann Made Media Puts AI Automation and AI Video on the Table for 2027 Plans - 15 November 2026
  • Balwin’s Black November Savings Land on Four Pretoria East Estates - 14 November 2026
  • RS SOUTH AFRICA APPOINTS KHUPHUKILE NDEBELE AS FINANCE DIRECTOR - 14 November 2026
  • Designer Pool Covers Passes 4,500 Installations as Automatic Cover Demand Grows - 14 November 2026
  • The Events Guys Brings Five Event Supply Tiers Under a Single Crew - 14 November 2026

Filed Under: Government

Footer

RSS Straton Electrical

  • Open Cycle Gas Turbine Usage
  • Flattening the curve – What Every Solar Installer Needs to Know
  • Why you shouldn’t leave a charger plugged in when not in use
  • How do I check if an Electrician is properly registered in South Africa?
  • Easy Electrical Troubleshooting for Humans
  • Water – If You Cannot Measure It Then You Cannot Manage It
  • Tips To Survive Loadshedding
  • Eskom’s Top 50 Electricity Saving Tips

RSS MyPE Business News

  • NMBBC On Budget 2025
  • Leading Business Minds Set to Headline Chambers Annual General Meeting
  • Bay of Opportunity Portal
  • Bay of Opportunity Ambassadors Programme to Promote the Bay and Attract Investment
  • 6 Decades of Trucking
  • Thermal Camera Installed at Redhouse Substation
  • Finalist in the 2025 South African Car of the Year
  • Joining hands to create a lasting impact to St Albans Primary School

RSS MyPR Press Releases

  • One Billion, Four Hundred and Fifty-Five Million, Seven Hundred and Ninety-Six Thousand, Eight Hundred and Forty-Six Times
  • Anchor Entrepreneur Awards announces 2026 finalists
  • Aremimo to Mark Fifth Anniversary With Grand Event in Addis Ababa on 5 December
  • Which Is Better: Petrol or Battery? That’s the Wrong Question
  • Two More Reasons for Brahman Hills to Celebrate!

How you may use MyPE content © 2026 MyPE · Gqeberha, South Africa | Privacy Policy | MyPE Ads and Media Kit